The low CD26-expression level here reported in ME/CFS may constitute therefore an adaptive response to the chronic redox imbalance found in ME/CFS patients [10–14 and the present study], this hypothesis being supported by the correlation we found between the CD26 activity and the redox status. This evidence concerns the gene DPP4 and myalgic encephalomeyelitis/chronic fatigue syndrome.